Newborn Genomes Programme
1st February 2022
Newborn Genomes Programme
We are co-designing and running an NHS-embedded research study to explore the benefits, challenges, and practicalities of sequencing and analysing the genomes of newborns.
The vision
Our increasing ability to harness the power and benefits of sequencing and analysing genomes for our healthcare could provide an opportunity to expand newborn screening from the present 9 conditions offered in the UK to many more rare diseases.
We are beginning a journey with parents, the public and health professionals to explore the many practical, ethical and societal questions around harnessing the power and benefits to diagnose and treat rare disease in newborns.
Related Link:
Citation: